Gaucher Disease is a condition where a specific enzyme, called β-glucocerebrosidase, is not produced correctly. This can lead to various health problems. The International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry is a worldwide program that helps doctors understand how Gaucher disease affects people over time. This program doesn't involve any new treatments. Instead, doctors check on patients in their usual care routine. One part of this program looks at women with Gaucher disease who are pregnant to see how the disease and pregnancy affect each other. The program collects information about the mothers and their babies up to three years after birth.
Key Points:
- No new treatment is given; doctors follow regular practices.
- Information is collected on both mother and infant, with consent.
- No exclusion criteria mean everyone diagnosed with Gaucher can join.